115 related articles for article (PubMed ID: 8464239)
1. Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Apr; 7(4):618-24. PubMed ID: 8464239
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
7. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
9. Effects of eleven cytokines and of IL-1 and tumor necrosis factor inhibitors in a human B cell assay.
Tucci A; James H; Chicheportiche R; Bonnefoy JY; Dayer JM; Zubler RH
J Immunol; 1992 May; 148(9):2778-84. PubMed ID: 1315359
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
11. B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.
Nerl C; Janssen O; Kabelitz D
Leukemia; 1988 Dec; 2(12 Suppl):50S-56S. PubMed ID: 3059076
[TBL] [Abstract][Full Text] [Related]
12. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
13. Divergent activities of protein kinases in IL-6-induced differentiation of a human B cell line.
Goldstein H; Koerholz D; Chesky L; Fan XD; Ambrus JL
J Immunol; 1990 Aug; 145(3):952-61. PubMed ID: 2165096
[TBL] [Abstract][Full Text] [Related]
14. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
Kashiwa H; Wright SC; Bonavida B
J Immunol; 1987 Mar; 138(5):1383-90. PubMed ID: 2949015
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of IL-4 and TNF-alpha in the induction of monocytic differentiation of a mouse myeloid leukaemic cell line (WEHI-3B JCS).
Leung KN; Mak NK; Fung MC; Hapel AJ
Immunology; 1994 Jan; 81(1):65-72. PubMed ID: 8132222
[TBL] [Abstract][Full Text] [Related]
16. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
17. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
[TBL] [Abstract][Full Text] [Related]
18. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
[TBL] [Abstract][Full Text] [Related]
19. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
20. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]